SAN DIEGO, June 19, 2026 /PRNewswire/ — Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, and MOTE Therapeutics, a preclinical-stage biotech company developing a novel targeted LNP delivery platform and in vivo CAR-T therapies, today…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
